SCHEMBL16628998

SCHEMBL16628998

Nc1ncc(-c2cccc(S(N)(=O)=O)c2)nc1I

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATR Q13535 4/20 0.49
CDK8 P49336 1/20 0.49
TYRO3 Q06418 2/20 0.48
PRKDC P78527 2/20 0.46
ATM Q13315 1/20 0.46
PIK3CD O00329 4/20 0.44
PIK3CA P42336 4/20 0.44
PIK3CG P48736 4/20 0.44
PIK3CB P42338 3/20 0.44
CA1 P00915 6/20 0.43
CA2 P00918 6/20 0.43
CA9 Q16790 5/20 0.43
CA12 O43570 3/20 0.43
CA4 P22748 2/20 0.43
ABL1 P00519 1/20 0.43
EGFR P00533 1/20 0.43
HCK P08631 1/20 0.43
SRC P12931 1/20 0.43
KDR P35968 1/20 0.43
MTOR P42345 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17657921 0.85 ALDH1A1 (0.50) ATRTYRO3PRKDCATMPIK3CD
SCHEMBL17657856 0.84 PIK3CD (0.53) ATRTYRO3PRKDCATMPIK3CD
SCHEMBL15308592 0.83 TYRO3 (0.50) ATRCDK8TYRO3PRKDCATM
SCHEMBL16628980 0.81 NPSR1 (0.53)
SCHEMBL16629017 0.81 JAK2 (0.55) ATRTYRO3PRKDCATMPIK3CD
SCHEMBL17657923 0.81 BRD4 (0.49) TYRO3PIK3CDPIK3CAPIK3CGPIK3CB
SCHEMBL17657874 0.81 PIK3CD (0.48) ATRTYRO3PRKDCATMPIK3CD
SCHEMBL17718279 0.80 TYRO3 (0.52) ATRCDK8TYRO3PRKDCATM
SCHEMBL19309232 0.80 PIK3CD (0.48) ATRCDK8TYRO3PRKDCATM
SCHEMBL28196773 0.77 NPC1 (0.61) CDK8CA1CA2CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015143012-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF PI3K-GAMMA MEDIATED DISORDERS INFINITY PHARMACEUTICALS, INC. (US) 2015-09-24 WO disclosed
WO-2015051241-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF INFINITY PHARMACEUTICALS, INC. (US) 2015-04-09 WO disclosed